| |
| |
|
| Insider
Information: |
Keating Laurie |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
23,298 |
|
|
Indirect Shares
|
434 |
|
|
| Direct
Value |
$829,774 |
|
|
|
Indirect Value
|
$64,419 |
|
|
| Total
Shares |
23,732 |
|
|
| Total
Value |
$894,192 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
EVP, Chief Legal Officer |
2021-08-05 |
5,132 |
2021-08-05 |
434 |
Premium* |
|
|
Immuneering Corp |
IMRX |
|
2022-05-16 |
14,000 |
2021-08-03 |
0 |
Premium* |
|
|
Pepgen Inc. |
PEPG |
Director |
2022-05-06 |
4,166 |
2022-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMRX |
Immuneering Corp |
|
– • – |
2022-05-16 |
4 |
B |
$5.00 |
$35,000 |
D/D |
7,000 |
14,000 |
0.01 |
- |
|
| IMRX |
Immuneering Corp |
Director |
– • – |
2021-08-03 |
4 |
B |
$15.00 |
$105,000 |
D/D |
7,000 |
7,000 |
2.39 |
- |
|
| PEPG |
Pepgen Inc. |
Director |
• • – |
2022-05-06 |
4 |
B |
$12.00 |
$49,992 |
D/D |
4,166 |
4,166 |
2.39 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2018-10-18 |
4 |
A |
$0.00 |
$0 |
I/I |
14 |
334 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2019-04-09 |
4 |
A |
$0.00 |
$0 |
I/I |
41 |
375 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2019-07-11 |
4 |
A |
$0.00 |
$0 |
I/I |
49 |
424 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2019-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
10 |
434 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-01-27 |
4/A |
OE |
$77.40 |
$283,516 |
D/D |
3,663 |
12,258 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-01-27 |
4 |
OE |
$42.22 |
$1,451,270 |
D/D |
34,374 |
49,632 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-01-27 |
4 |
AS |
$115.55 |
$4,829,970 |
D/D |
(41,037) |
8,595 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-01-29 |
4 |
AS |
$119.00 |
$754,103 |
D/D |
(6,337) |
8,595 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-01-29 |
4 |
OE |
$77.40 |
$490,484 |
D/D |
6,337 |
14,932 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-02-10 |
4 |
AS |
$129.00 |
$1,290,000 |
D/D |
(10,000) |
12,258 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-02-10 |
4 |
OE |
$77.40 |
$774,000 |
D/D |
10,000 |
22,258 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-04-07 |
4 |
D |
$104.75 |
$202,548 |
D/D |
(1,933) |
14,492 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,167 |
16,425 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-04-20 |
4 |
OE |
$77.40 |
$774,000 |
D/D |
10,000 |
24,492 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-04-20 |
4 |
AS |
$139.00 |
$1,390,000 |
D/D |
(10,000) |
14,492 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-07-13 |
4 |
AS |
$157.16 |
$7,591,790 |
D/D |
(47,250) |
2,992 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2020-07-13 |
4 |
OE |
$42.22 |
$3,116,066 |
D/D |
35,750 |
50,242 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2021-01-11 |
4 |
AS |
$154.00 |
$116,732 |
D/D |
(758) |
2,234 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2021-01-12 |
4 |
OE |
$42.22 |
$1,088,149 |
D/D |
14,941 |
17,175 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2021-01-12 |
4 |
AS |
$159.00 |
$2,393,619 |
D/D |
(14,941) |
2,234 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2021-01-13 |
4 |
AS |
$169.00 |
$1,533,698 |
D/D |
(9,027) |
2,234 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
• – – |
2021-01-13 |
4 |
OE |
$77.40 |
$744,290 |
D/D |
9,027 |
11,261 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
